On this episode of WellBuilt, Jon spoke to Dylan Beynon, Founder & CEO of Mindbloom. 

Mindbloom provides at-home ketamine therapy. 

In their conversation, they got into Dylan’s personal reasons for starting Mindbloom, and how they came up with their telehealth model for helping people combat anxiety or depression, and improve their mental health. 

Since ketamine treatments are currently one of the only legal forms of psychedelic-assisted therapy, which other promising psychedelics such as psilocybin and MDMA pending FDA approvals for therapeutic use - many digital and in-person ketamine-focused companies have recently propped up. This increase in access has also led to concerns and critique around potential side effects, addictiveness, and the overall health impact of prolonged use. 

Dylan was happy to dive into where the industry stands, unpack some of the critiques in recent hit pieces, and share his thoughts about how we can think about the industry’s goals for long-term safety and efficacy. 

It was also great to learn about Dylan’s passion for health and wellness and personal development, as well as how he strives to create a culture of empowerment, accountability, and continuous learning at Mindbloom. 

Check out Mindbloom, and enjoy!